Parabilis Soared Biggest Biotech: Is It Too Late to Buy?
A record biotech IPO backdrop has investors buzzing about Parabilis Medicines. This guide breaks down what the surge ...
Ways To Get Quick Cash Today
Explore various ways to get quick cash today. These strategies will help you access funds when you need them most.
23,336 articlesBailey Zimmerman Faces Felony: Financial Fallout for a Rising Star
When a high-profile artist hits legal trouble, the financial ripple effects can be wide. This article looks at how ba...
Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Cathie Wood Just Bought SpaceX Dip Again, Alibaba Trimmed
ARK Invest doubled down on SpaceX after a market pullback, funding the move by trimming Alibaba. The trade underscore...
IBM Suffers Worst Stock Crash as Market Turmoil Intensifies
IBM’s dramatic one-day plunge coincided with blockbuster bank profits, fueling a debate over whether markets are misp...
This $38.8 Million Vicor Bet Sparks a 200% Surge
A major fund boosted its Vicor stake, sending the stock higher as a 200% rally unfolds. This article unpacks the bet,...
These Fintech Stocks Loved by Analysts Could Rally Big
Analysts are warming to a pair of fintech names as valuations cool and growth metrics improve. This report explains w...
Billionaire Philippe Laffont Dumped CoreWeave Stake
Seasonal 13F filings shed light on big moves by top money managers. This article breaks down a notable shift: billion...
Lucid Group (LCID) Stock Forecast: 2026 to 2030 Outlook
Lucid Group faces a bumpy road as the EV market evolves. This report outlines 2026-2030 price paths for lucid group (...
Accelerant Sells $638K Stock: What That Means for Investors
When a chief financial officer sells a sizable chunk of stock, it draws attention. This article breaks down the impli...
Willdan Stock Skyrocketing: Fund Cashout Shocks Investors
Willdan stock skyrocketing has investors buzzing as one large fund sold about $7.74 million worth of shares. This art...
Monashee Scales Back Structure: GPCR Bet Reassessed
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status